malondialdehyde has been researched along with Myelodysplastic Syndromes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa, MC; Carvalho, TM; de Freitas, RM; de Souza, GF; Gonçalves, RP; Magalhães, SM; Martins, MR; Pinheiro, RF; Santos, TE | 1 |
Čermák, J; Chrastinová, L; Dyr, JE; Kotlín, R; Pimková, K; Štikarová, J; Suttnar, J | 1 |
Bamonti-Catena, F; Carrabba, M; Cavalca, V; Cighetti, G; Cortelezzi, A; Fracchiolla, NS; Lambertenghi Deliliers, G; Maiolo, AT; Motta, M | 1 |
Cappellini, MD; Cattaneo, C; Cortelezzi, A; Cristiani, S; Deliliers, GL; Duca, L; Fiorelli, G; Sarina, B | 1 |
4 other study(ies) available for malondialdehyde and Myelodysplastic Syndromes
Article | Year |
---|---|
Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Humans; Iron Overload; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myelodysplastic Syndromes; Nitrites; Oxidative Stress; Transfusion Reaction | 2013 |
Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload.
Topics: Case-Control Studies; Dipeptides; Ferritins; Humans; Iron; Iron Overload; Malondialdehyde; Myelodysplastic Syndromes; Nitrates; Nitrites; Oxidation-Reduction; Oxidative Stress; Sulfhydryl Compounds; Treatment Outcome | 2014 |
Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease.
Topics: Analysis of Variance; Autoimmunity; Cardiovascular Diseases; Case-Control Studies; Fasting; Homocysteine; Humans; Hyperhomocysteinemia; Lipid Peroxidation; Malondialdehyde; Myelodysplastic Syndromes; Oxidative Stress | 2001 |
Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?
Topics: Apoptosis; Biomarkers; Bone Marrow Cells; Cell Division; Colony-Forming Units Assay; DNA Damage; Erythropoiesis; Female; Ferritins; Humans; Iron; Karyotyping; Lipid Peroxidation; Male; Malondialdehyde; Myelodysplastic Syndromes; Reference Values; Reticulocyte Count; Transferrin | 2000 |